Migraine Patch
Links shared publicly online about this topic
Zelrix, A Migraine Patch, Is Moving Forward
medgadget.com — “medgadget -- medical technologies weblog” View full resource at medgadget.com
Most Recently Shared on August 14, 2009 at 8:13 pm By:
Stephen Roberts, MD Physician and Doctor
Zelrix, A #Migraine Patch, Is Moving Forward http://ow.ly/kR7T Potentially valuable for those with nausea & vomiting.
Migraine Patch Rejected by FDA | ThirdAge
thirdage.com — “NuPathe Inc's new migraine patch Zelrix has been rejected by the FDA, causing the likely release date to be pushed back six months.” View full resource at thirdage.com
Most Recently Shared on August 30, 2011 at 3:59 pm By:
Migraine Patch Rejected by FDA http://t.co/ncrLZyz
Migraine Patch Rejected by FDA | ThirdAge
thirdage.com — “NuPathe Inc's new migraine patch Zelrix has been rejected by the FDA, causing the likely release date to be pushed back six months.” View full resource at thirdage.com
Most Recently Shared on August 31, 2011 at 8:15 pm By:
Migraine Patch Rejected by FDA http://t.co/IB31njG
Zelrix Migraine Patch - FDA Approval Delayed | Migraine.com
migraine.com — “The FDA issued a Complete Response Letter regarding the Migraine sumatriptan patch Zelrix, delaying FDA approval of this new medication.” View full resource at migraine.com
Most Recently Shared on September 6, 2011 at 3:11 pm By:
Zelrix #Migraine Patch - FDA Approval Delayed | Migraine.com http://t.co/vrblu5H via @MigraineDotCom @NupatheInc
NuPathe migraine patch fails to get FDA approval
sfgate.com — “NuPathe, a maker of neurological and psychiatric medicines, fell 35 percent in New York trading after failing to win U.S. approval for the first skin patch to treat migraines. NuPathe slid $1.40 to $2.65 on the Nasdaq....” View full resource at sfgate.com
Most Recently Shared on August 31, 2011 at 7:04 am By:
NuPathe migraine patch fails to get FDA approval: NuPathe, a maker of neurological and psychiatric medicines, fe... http://t.co/FT3ML0o
FDA Rejects NuPathe Migraine Patch - TheStreet
thestreet.com — “NuPathe may need to conduct additional studies before resubmitting Zelrix for approval again.” View full resource at thestreet.com
Most Recently Shared on August 30, 2011 at 12:43 pm By:
FDA Rejects NuPathe Migraine Patch: CONSHOHOCKEN, Pa. (TheStreet) -- U.S. regulators rejected NuPathe's migraine... http://t.co/CjQasgc
NuPathe to resubmit migraine patch for approval in 2012
medcitynews.com — “NuPathe, an emerging biopharmaceutical company, received a complete response letter from the FDA. Read about what the company is doing to address it.” View full resource at medcitynews.com
Most Recently Shared on November 15, 2011 at 5:52 pm By:
NuPathe to resubmit migraine patch for approval in 2012: NuPathe (NASDAQ: PATH) said it will resubmit a new drug... http://t.co/GuXqAlQa
Zelrix electronic anti-migraine patch heads to the FDA for review -- Engadget
engadget.com — “Zelrix electronic anti-migraine patch heads to the FDA for review -- Engadget” View full resource at engadget.com
Most Recently Shared on January 24, 2011 at 5:59 am By:
Zelrix electronic anti-migraine patch heads to the FDA for review: We've seen some electronic devices that prom... http://engt.co/f4lztK
Migraine-Treating Bandages - The Zelrix Migraine Patch Fights Migraines With Electric Medication
trendhunter.com — “Zelrix Migraine Patch - Migraine sufferers are about to get one more treatment option in the form of the new Zelrix Migraine Patch. The Zelrix Migraine Patch has recently ...” View full resource at trendhunter.com
Most Recently Shared on January 26, 2011 at 9:29 pm By:
Trend Hunter Health Health Magazine
Migraine-Treating Bandages - The Zelrix Migraine Patch Fights Migraines With Electric Medication #Health: http://bit.ly/fkkRSU
NuPathe shares in meltdown after FDA rejects migraine patch app - FierceBiotech
fiercebiotech.com — “The FDA has handed NuPathe a complete response letter detailing demands for new information on its experimental migraine patch, Zelrix (NP101). But even after scrambling to try and reassure investors Read more...” View full resource at fiercebiotech.com
Most Recently Shared on August 30, 2011 at 12:34 pm By:
NuPathe shares in meltdown after FDA rejects migraine patch app. http://t.co/JAMKwAX
NuPathe says FDA did not approve migraine patch - Yahoo! News
news.yahoo.com — “Read 'NuPathe says FDA did not approve migraine patch' on Yahoo! News. NuPathe Inc. said Tuesday that regulators did not approve its Zelrix migraine patch, and the company's shares lost almost half their value.” View full resource at news.yahoo.com
Most Recently Shared on August 30, 2011 at 6:51 pm By:
NuPathe says FDA did not approve migraine patch: NuPathe Inc. said Tuesday that regulators did not approve its ... http://t.co/MFsotoL
FDA Requests Additional Information Regarding NuPathe's Migraine Patch in Complete Response Letter
marketwire.com — “CONSHOHOCKEN, PA--(Marketwire - Aug 30, 2011) - NuPathe Inc. (NASDAQ: PATH) today announced that it has received a Complete Response Letter (CRL) from the U.S. Food @ Drug Administration (FDA) regarding the New Drug Application (NDA) for its migraine patch (NP101 or Zelrix). A CRL is issued by the FDA's...” View full resource at marketwire.com
Most Recently Shared on August 30, 2011 at 12:43 pm By:
FDA Requests Additional Information Regarding NuPathe's Migraine Patch in Complete Response Letter: CONSHOHOCKE... http://t.co/rhjDXXz
NuPathe migraine patch works in late-stage study | Reuters
feeds.reuters.com — “CHICAGO (Reuters) - NuPathe Inc's skin patch eased migraine symptoms in a late-stage study, offering a potential new way to treat migraine without taking pills, the specialty drugmaker said on Tuesday. The” View full resource at feeds.reuters.com
Most Recently Shared on August 11, 2009 at 10:51 pm By:
NuPathe migraine patch works in late-stage study http://link.reuters.com/puv22d
Pharma: NuPathe Migraine Patch Rejected; Another Blood Thinner Misses Results - Yahoo! News
news.yahoo.com — “Read 'Pharma: NuPathe Migraine Patch Rejected; Another Blood Thinner Misses Results' on Yahoo! News. Shares of NuPathe (PATH) are plunging today after the pharma company said the U.S. Food and Drug Administration declined to approve its Zelrix migraine patch.The FDA issued a complete response letter to the company, in which it acknowledge the established efficacy of the treatment, but raised questions regarding the chemistry, manufacturing and safety of the patch.NuPathe said it believe that it ” View full resource at news.yahoo.com
Most Recently Shared on August 30, 2011 at 6:51 pm By:
Pharma: NuPathe Migraine Patch Rejected; Another Blood Thinner Misses Results: Shares of NuPathe (PATH) are plu... http://t.co/S7lO7Gg
NuPathe Falls After Failing to Win Migraine Patch Approval - Businessweek
businessweek.com — “NuPathe Inc., a maker of neurological and psychiatric medicines, fell 35 percent in New York trading after failing to win U.S. approval for the first skin patch to treat migraines.” View full resource at businessweek.com
Most Recently Shared on August 30, 2011 at 6:51 pm By:
NuPathe Falls After Failing to Win Migraine Patch Approval: NuPathe Inc., a maker of neurological and psychiat... http://t.co/U52Jvna
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Featuring the top 3 experts for this topic
-
Stephen Roberts, MD
-
ThirdAge.com
A boomer's guide to a life of health, happiness, passion & purpose.
-
ThirdAge
A boomer's guide to a life of health, happiness, passion & purpose.
Advertisement
